JAMESBURG, N.J., Jan 28 /PRNewswire/ -- Phytomedics Inc., a clinical stage biopharmaceutical company developing novel multi-component / multi-targeted drug products, announced today that it will present at the Wachovia 2008 Healthcare Conference in Boston, Massachusetts on Wednesday, January 30th, at 1:00 p.m. ET.
Among the topics of the presentation will be an overview of Phytomedics strategic focus and business developments, including Phase III development activities related to its lead drug candidate, PMI-001 for rheumatoid arthritis, as well the continued development of additional clinical candidates in its drug pipeline, including products for Type II diabetes, obesity, and age-related frailty.
About Phytomedics Inc.
Phytomedics Inc. (www.phytomedics.com) uses a broad and innovative proprietary technology platform to discover, develop, manufacture, and commercialize novel, multi-component and multi-targeted drug products derived from natural sources.
CONTACT: Ira S. Pastor, Executive VP of Phytomedics Inc., +1-609-655-0715,
pastor@phytomedics.com
Web site: http://www.phytomedics.com//
